SS
Sampat Singh Bhati
About Sampat Singh Bhati
Data last updated:
Sampat Singh Bhati is a Director at Urban Leaf Ventures Private Limited (since 2024) and Director at Biomedische Lifesciences Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Urban Leaf Ventures Private Limited at ₹60.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Urban Leaf Ventures Private Limited U56301RJ2023PTC086027 | Director | 24 Aug 2024 | 2023 | ₹60.9 Lakh (FY 2025) | Active |
| Biomedische Lifesciences Private Limited U46497TS2024PTC184141 | Director | 04 Apr 2024 | 2024 | Active |
Board colleagues of Sampat Singh Bhati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajendra Khatri | 10050108 | Urban Leaf Ventures Private Limited | Director |
| Ranveer Choudhary | 10050109 | Urban Leaf Ventures Private Limited | Director |
| Prateek Deora | 10579223 | Biomedische Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sampat Singh Bhati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sampat Singh Bhati
Sampat Singh Bhati currently holds 2 directorships: Urban Leaf Ventures Private Limited (Director, since 24 Aug 2024, revenue ₹60.9 Lakh (FY 2025)); Biomedische Lifesciences Private Limited (Director, since 04 Apr 2024).
Sampat Singh Bhati was first appointed on 04 Apr 2024 as Director at Biomedische Lifesciences Private Limited.
The current boards of Sampat Singh Bhati's companies include Rajendra Khatri (Urban Leaf Ventures Private Limited), Ranveer Choudhary (Urban Leaf Ventures Private Limited), Prateek Deora (Biomedische Lifesciences Private Limited).